Fresenius Medical Care Corporation (FMS)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $11.43B
Last updated: Nov 17, 2026 at 4:33 PM ET
Fresenius Medical Care Corporation (FMS) Statistics
Fresenius Medical Care (FMS) has a market cap of $11.43B. Its share count is down 10.38% from a year earlier. Its dividend yield is 4.02%.
Total Valuation
| Market Cap | $11.43B |
|---|---|
| Latest price (Nov 17, 2026) | $21.70 |
Key Dates
The last ex-dividend date was May 22, 2026.
| Last Earnings Date | Nov 3, 2026 |
|---|---|
| Last Ex-Dividend Date | May 22, 2026 |
| Last Payment Date | Jun 8, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.5x and 0.8x.
| P/E Ratio | 8.8x |
|---|---|
| P/S Ratio | 0.5x |
| P/B Ratio | 0.8x |
| P/FCF Ratio | 5.6x |
| PEG Ratio | 0.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.4x EBITDA and 9.1x free cash flow.
| EV / EBITDA | 5.4x |
|---|---|
| EV / FCF | 9.1x |
Price Statistics
The stock is down 7.25% over 52 weeks and trades 2.52% below its 50-day average.
| Beta (1Y) | 0.08 |
|---|---|
| 52-Week Change | -7.25% |
| 1-Month Change | -1.12% |
| 3-Month Change | -9.00% |
| 6-Month Change | +2.12% |
| 5-Year Change | -32.38% |
| 10-Year Change | -44.63% |
| Total Return (1Y) | -3.52% |
| Total Return (3Y CAGR) | +5.13% |
| Total Return (5Y CAGR) | -5.54% |
| Return vs SPY (1Y) | -17.03% |
| Max Drawdown (1Y) | -19.50% |
| Max Drawdown (3Y) | -34.19% |
| Sharpe Ratio (1Y) | -0.18 |
| Correlation with SPY (1Y) | 0.04 |
| 50-Day Average | $22.26 |
| 200-Day Average | $22.56 |
| 52-Week Range | $19.24 to $26.42 |
| RSI (14 Days) | 43.9 |
| Average Volume (20 Days) | 1.54M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.99x current liabilities, and total debt is 0.59x shareholder equity.
| Current Ratio | 0.99x |
|---|---|
| Quick Ratio | 0.69x |
| Debt / Equity | 0.59x |
| Debt / EBITDA | 2.49x |
| Interest Coverage | 4.59x |
Returns and Efficiency
Return on invested capital is 6.88% over the last 12 months, against a 5-year average of 5.25%.
| Return on Equity (ROE) | 6.56% |
|---|---|
| Return on Assets (ROA) | 2.67% |
| Return on Invested Capital (ROIC) | 6.88% |
| Return on Capital Employed (ROCE) | 7.54% |
| ROE (5Y Average) | 5.33% |
| ROA (5Y Average) | 2.19% |
| ROIC (5Y Average) | 5.25% |
| Asset Turnover | 0.62x |
| Inventory Turnover | 6.11x |
| Receivables Turnover | 5.70x |
| Cash Conversion Cycle | 101 days |
Taxes
Income tax took 22.61% of pretax income over the last 12 months.
| Income Tax (TTM) | EUR 316.86M |
|---|---|
| Effective Tax Rate | 22.61% |
Scores
FMS has an Altman Z-Score of 1.70, in the distress zone below 1.81, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.70 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of EUR 19.48B over the last 12 months is down 0.83% from the 12 months before.
| Revenue | EUR 19.48B |
|---|---|
| Revenue Growth (YoY) | -0.83% |
| Gross Profit | EUR 5.15B |
| Operating Income | EUR 1.77B |
| Pretax Income | EUR 1.40B |
| Net Income | EUR 822.76M |
| EBITDA | EUR 2.97B |
| EBIT | EUR 1.77B |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 40.67% of the EUR 31.45B in total assets.
| Working Capital | EUR -65.59M |
|---|---|
| Shareholder Equity | EUR 12.79B |
| Tangible Book Value | EUR -2.48B |
| Total Assets | EUR 31.45B |
| Total Liabilities | EUR 17.69B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After EUR 1.08B of capital spending, operating cash flow left EUR 1.78B of free cash flow.
| Operating Cash Flow | EUR 2.86B |
|---|---|
| Capital Expenditures | EUR 1.08B |
| Free Cash Flow | EUR 1.78B |
| Depreciation and Amortization | EUR 1.63B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 9.06%, against a 5-year average of 8.45%.
| Gross Margin | 26.46% |
|---|---|
| Operating Margin | 9.06% |
| Pretax Margin | 7.20% |
| Net Margin | 4.22% |
| EBITDA Margin | 15.27% |
| EBIT Margin | 9.11% |
| FCF Margin | 9.14% |
| Gross Margin (5Y Average) | 25.57% |
| Operating Margin (5Y Average) | 8.45% |
| Net Margin (5Y Average) | 3.86% |
Growth
Revenue grew 0.39% a year over 3 years.
| Revenue Growth (3Y CAGR) | +0.39% |
|---|---|
| Revenue Growth (5Y CAGR) | +1.91% |
| FCF Growth (3Y CAGR) | +30.91% |
| FCF Growth (5Y CAGR) | -4.59% |
| Operating Income Growth (3Y CAGR) | +6.51% |
Dividends and Yields
FMS pays out 48.06% of earnings as dividends.
| Dividend Per Share (Annual) | $0.87 |
|---|---|
| Dividend Yield | 4.02% |
| Payment Schedule | Annual |
| Dividend Growth (3Y CAGR) | +4.74% |
| Dividend Growth (5Y CAGR) | +2.88% |
| Payout Ratio | 48.06% |
| Earnings Yield | 11.36% |
| FCF Yield | 18.01% |
Stock Splits
The last split was a 2-for-1 forward split on Dec 4, 2012.
| Last Split Date | Dec 4, 2012 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, FMS has the 12th highest P/E and the lowest P/S.
P/E RatioPeer median 23.6x
P/S RatioPeer median 1.6x
ROICPeer median 12.96%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.19%
Dividend YieldPeer median 0.00%
| P/E Ratio | 8.8x vs 23.6x median |
|---|---|
| P/S Ratio | 0.5x vs 1.6x median |
| ROIC | 6.88% vs 12.96% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -0.83% vs +7.19% median |
| Dividend Yield | 4.02% vs 0.00% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About FMS
What is FMS's market cap?
Fresenius Medical Care has a market cap of $11.43B.
What is FMS's P/E ratio?
Fresenius Medical Care has a trailing P/E ratio of 8.8x.
How many shares of FMS are outstanding?
Fresenius Medical Care has 524.00M shares outstanding. The count is down 10.38% from a year earlier.
Does FMS pay a dividend?
Yes. Fresenius Medical Care pays $0.87 a share a year, a dividend yield of 4.02%.
FMS pages: Overview, Dividends, Charting, Financials, Statistics, Valuation, Competitors